Ignite Creation Date:
2024-05-05 @ 11:36 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00090675
Status:
WITHDRAWN
Last Update Posted:
2013-01-29
First Post:
2004-09-02
Brief Title:
Maintenance ZD1839 IRESSA Following Completion of Front Line Platinum-Based Double Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-01
Start Date Type:
None
Primary Completion Date:
2007-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2007-11
Completion Date Type:
ESTIMATED
First Submit Date:
2004-09-02
First Submit QC Date:
September 2 2004
Study First Post Date:
2004-09-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-01-28
Last Update Post Date:
2013-01-29
Last Update Post Date Type:
ESTIMATED